Four possible types of nootropic drugs are classified theoretically according to their possible effects on cognitive functions. Among the factors usually varied in psychopharmacological designs, the significance of the time of application of the drug is stressed. Considering the relations between the time of application of nootropic drugs within standardized experimental plans and their effects on cognitive processes, ideal time of application-response curves for each of these types of nootropic compounds are proposed. These curves may represent experimental tools in investigating the mode of action of nootropic drugs. Finally, some experimental results are presented which are relevant to this approach. Overall, however, the rationale of these theoretical considerations remains largely unproven because of the lack of studies to date designed to evaluate the mechanisms of drug action by varying the time of application of a nootropic compound.

Keywords:
Nootropic drugs, Learning, Memory, Experimental design, Drug action model
This content is only available via PDF.
© 1986 S. Karger AG, Basel
1986
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.